3 Pharmaceutical Stocks Under $10 to Buy in September By StockNews
The pharmaceutical industry’s increased focus on developing better treatments for many of today’s most complex diseases should help it to grow for the foreseeable future. High-priced pharma stocks could face market volatility, so we recommend investing in high quality stocks like Kamada, Catalyst Pharmaceuticals, and Kamada (NASDAQ). These stocks are trading at very affordable prices. Let’s discuss.According to ReportLinker, the global pharmaceutical contract development and manufacturing market size is expected to grow at an 8.6% CAGR to $162.69 billion by 2026. The stock market will remain volatile due to concerns about the effect of increasing COVID-19 cases and economic recovery. However, high-priced pharma stocks could see a decline in near future.
So, we think it could be wise to bet now on fundamentally sound stocks Amneal Pharmaceuticals, Inc. (AMRX), Catalyst Pharmaceuticals, Inc. (CPRX), and Kamada Ltd . (KMDA), are trading below $10.
Click here to checkout our Healthcare Sector Report for 2021
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.